Search the Cancer Center site

Home
About
About

Located in Worcester, Massachusetts, the UMass Cancer Center is committed to providing exceptional patient care, conducting cutting-edge research at the highest level, offering excellence in education and training, and serving as an educational resource and advocate for the Central Massachusetts community.
Patients
Patients

Expert Cancer Care in Central Massachusetts

We offer comprehensive cancer care for all childhood and adult cancers, combining state-of-the-art treatments with compassionate support for patients and their families.
Clinicians
Research
Research

Cutting-Edge Cancer Research

We carry out front-line research in basic, translational, clinical and population-based discovery to find newer, better methods for the prevention, detection, diagnosis, and treatment of cancer.
Education
Education

World Class Medical and Scientific Education

The UMass Cancer Center is dedicated to training the next generation of cancer researchers, clinicians and physician-scientists.
Outreach
Michael Green Memorial
Michael Green Memorial

UMass Chan lost one of its greats when Michael R. Green, MD, PhD, passed away unexpectedly in February 2023. We've established these web pages in his memory so our visitors can take a few minutes, from time to time, to peruse and remember him.

Donate to the The Michael R. Green, MD, PhD, Award in Graduate Research:

Donate

Additional Resources

Muthalagu Ramanathan, MD

Professor, Department of Medicine/Division of Hematology-Oncology; Director, Myeloma Program; Co-Director of Blood and Bone Marrow Transplant Program, UMass Chan Medical School

Page Menu

Muthalagu Ramanathan, MD

Research Focus - Multiple Myeloma Clinical Research

Bringing in novel treatment clinical trials in multiple myeloma such as CAR T cells and bispecific antibodies
Using maintenance daratumumab in addition to Revlimid (lenalidomide) after stem cell transplant

Representative Publication

Wang X, Vogt B, Shanahan L, et al. Elotuzumab-based maintenance therapy following autologous stem cell transplant in multiple myeloma deepens post-transplant responses. Blood Cells Mol Dis. 2020;85:102482.

Read Publication

More Publications

Clinical Trials

View more trials at Conquering Diseases